Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia

NCT01235117 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: azacitidine
OTHER: laboratory biomarker analysis

Sponsor

University of Leeds